• Nenhum resultado encontrado

Association between the STK15 F31I polymorphism and cancer susceptibility: a meta-analysis involving 43,626 subjects.

N/A
N/A
Protected

Academic year: 2017

Share "Association between the STK15 F31I polymorphism and cancer susceptibility: a meta-analysis involving 43,626 subjects."

Copied!
13
0
0

Texto

Loading

Imagem

Figure 1.  Flow diagram of articles selection process for STK15 F31I polymorphism and cancer risk meta-analysis
Table 1. Characteristics of populations and cancer types of the individual studies included in the meta-analysis.
Table 5. Summary of results of the meta-analysis from different comparative genetic models in the breast cancer subgroup analysis by ethnicity.
Figure 2.  Meta-analysis with a random-effects model for the association between the risk of cancer and the STK15 F31I polymorphism (A vs
+3

Referências

Documentos relacionados

Thus, the objective of the present study was to deter- mine the allelic and genotypic frequencies of the STK15 F31I polymorphism in 750 healthy women and also to in- vestigate

nels (VGSC) in the progression of different tumors, such as prostate cancer, small cell lung cancer, breast cancer and others, linking VGSC to the invasion capacity of tumor cells (4

Forest plot from the meta-analysis of colorectal cancer and CYP2C9 I359L polymorphism using dominant genetic model... complex disease, and both environmental and genetic factors

BACKGROUND: The role of immune system in the pathogenesis and progression of breast cancer is a subject of controversy, and this stimulated us to investigate the association of

Of these, cell part (cytoplasmic proteins) and organelle-associated (chromosome, cytoplasmic membrane- bounded vesicles, cytoskeleton, endoplasmic reticulum, endosome,

Based on literature reports on overexpression of HER-2/Neu in many human tumours, including gastric cancer, and the good response of advanced breast cancer to a specific

Several proteins have been studied in relation to the development and progression of colorectal cancer, including tumor protein p53 (p53) and antigen identiied by monoclonal

Studies included had to meet the following criteria: evaluate the association between PARP1 Val762Ala polymorphism and cancer risk; case-control study design; sufficient information